On Wednesday, March 2, Dr. Polly Newcomb and her colleagues published a study in the British Journal of Cancer about an association between a type of osteoporosis drug and lowered risk of breast cancer. Dr. Newcomb's research focus is the practical and targeted prevention of breast and colon cancer. There were a lot of media hits on this story, and below are just a few highlights:
Hutchinson Center press release
http://www.fhcrc.org/about/ne/news/2010/03/02/osteoporosis.html
Bone loss drug may decrease women's breast cancer risk
Bone-loss drugs may reduce breast-cancer risk, study shows
Osteoporosis drugs may help protect women against cancer
One interesting thing to note about Dr. Newcomb's study is that it involved nearly 6,000 Wisconsin women, aged 20-69, and it was done in collaboration with researchers at the University of Wisconsin Carbone Cancer Center in Madison...our home away from home!
0 comments:
Post a Comment